Breakthrough technologies to be launched at med conclave
TNN | Mar 24, 2019, 04:27 IST
Thiruvananthapuram: Innovative devices and technologies, including that for detection of TB bacterium, viewing veins prior to injections and for ventricular support in case of severe heart ailments, will hog the limelight at the ‘3rd Technology Conclave’ of the Sree Chitra Tirunal Institute of Medical Sciences and Technology (SCTIMST) to be held here on Sunday.
Coinciding with the ‘World TB Day’, which falls on March 24, the institute will transfer to the industry partner its new technology of isothermal-based DNA amplification device to detect TB bacterium in sputum samples in less than 30 minutes. “The device will provide a breakthrough in the rapid diagnosis of tuberculosis, and SCTIMST has already filed the patent application for this technology,” institute director Asha Kishore said here on Saturday.
“The new TB detection device needs no qualified technicians or specialized laboratory setups, and it can simultaneously screen 20 patient samples in one assay and at a lower cost than the existing devices, which costs around Rs 2,500/sample,” the SCTIMST director said. “The device will help in mass screening through primary health centres (PHCs) at a very low cost,” she pointed out.
The conclave, which would also feature industry-innovator meet and medical technology expo at the Biomedical Technology Wing campus at Poojappura, will witness commercial launch of a vein viewer system, which will help healthcare professionals locate the vein and correctly insert the needle in a single needle prick, and DRIPO Infusion monitor for precisely monitoring and controlling the rate of flow of intravenous drugs.
Among the new technologies to be transferred to industry partners are paracorporeal left ventricular assist device for supporting heart after cardiac surgeries or while awaiting a donor heart, PT/INR monitoring device for easy measurement of blood clotting parametres, injectable hydrogel for cartilage repair in joints and lint free absorbent wound dressing.
The conclave will also see relicensing of various other technologies. There will be brainstorming sessions about emerging trends in biomedical technology.
Coinciding with the ‘World TB Day’, which falls on March 24, the institute will transfer to the industry partner its new technology of isothermal-based DNA amplification device to detect TB bacterium in sputum samples in less than 30 minutes. “The device will provide a breakthrough in the rapid diagnosis of tuberculosis, and SCTIMST has already filed the patent application for this technology,” institute director Asha Kishore said here on Saturday.
“The new TB detection device needs no qualified technicians or specialized laboratory setups, and it can simultaneously screen 20 patient samples in one assay and at a lower cost than the existing devices, which costs around Rs 2,500/sample,” the SCTIMST director said. “The device will help in mass screening through primary health centres (PHCs) at a very low cost,” she pointed out.
The conclave, which would also feature industry-innovator meet and medical technology expo at the Biomedical Technology Wing campus at Poojappura, will witness commercial launch of a vein viewer system, which will help healthcare professionals locate the vein and correctly insert the needle in a single needle prick, and DRIPO Infusion monitor for precisely monitoring and controlling the rate of flow of intravenous drugs.
Among the new technologies to be transferred to industry partners are paracorporeal left ventricular assist device for supporting heart after cardiac surgeries or while awaiting a donor heart, PT/INR monitoring device for easy measurement of blood clotting parametres, injectable hydrogel for cartilage repair in joints and lint free absorbent wound dressing.
The conclave will also see relicensing of various other technologies. There will be brainstorming sessions about emerging trends in biomedical technology.
more from times of india Cities
LATEST VIDEOS
All Comments ()+^ Back to Top
Refrain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks, name calling or inciting hatred against any community. Help us delete comments that do not follow these guidelines by marking them offensive. Let's work together to keep the conversation civil.
HIDE